Sun Pharma Q3 net profit up 15%; revenue at `13,675 crore

PTI NEW delhi

Sun Pharmaceutical Industries on Friday said its consolidated net profit increased 15 per cent on-year to Rs 2,903 crore in the December quarter, riding on robust sales across geographies.

The drug major had reported a net profit of Rs 2,524 crore in the October-December quarter of last fiscal. Total revenue from operations rose to Rs 13,675 crore in the third quarter compared to Rs 12,381 crore in the year-ago period, Sun Pharma said in a regulatory filing.

The company said its board has declared an interim dividend of Rs 10.5 per share for the year FY25 against Rs 8.50 per share interim dividend for the previous year. "Our performance in the quarter showed all-round improvement. Product sales in Global Specialty crossed 1/5th of overall sales," Sun Pharma Chairman and Managing Director Dilip Shanghvi said.

"Our market share gain in India has been driven by industry-leading volume growth. Emerging Markets demonstrated strong performance in spite of currency challenges across geographies," he added.